Insurance in Greece

Insurance in Greece

Summary

Insurance in Greece industry profile provides top-line qualitative and quantitative Summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Essential resource for top-line data and analysis covering the Greece insurance market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key Highlights

- The insurance market consists of the non-life insurance sector and the life insurance sector. The value of the market is shown in terms of gross premium incomes.
- The Greek insurance market had total gross written premiums of $4.4bn in 2017, representing a compound annual rate of change (CARC) of -1% between 2013 and 2017.
- The non-life segment was the markets most lucrative in 2017, with total gross written premiums of $2.4bn, equivalent to 55% of the markets overall value.
- According to Swiss Re, Greek insurance penetration is significantly below the European average, at 2.2% of GDP in 2017 compared to 6.5%. The austerity programme decimated purchasing power and disposable incomes in the country, meaning savings are no longer an option. OECD data shows that Greek household savings were negative in 2016, suggesting costs were outstripping incomes and many were entering debt. This has ballooned since 2009, making it difficult for Greeks to put aside for investment products such as insurance.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the insurance market in Greece
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the insurance market in Greece
- Leading company profiles reveal details of key insurance market players global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Greece insurance market with five year forecasts

Reasons to buy

- What was the size of the Greece insurance market by value in 2017?
- What will be the size of the Greece insurance market in 2022?
- What factors are affecting the strength of competition in the Greece insurance market?
- How has the market performed over the last five years?
- Who are the top competitiors in Greeces insurance market?

Executive Summary 2
Market value 2
Market value forecast 2
Category segmentation 2
Geography segmentation 2
Market share 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 9
Market value 9
Market Segmentation 10
Category segmentation 10
Geography segmentation 11
Market share 12
Market Outlook 13
Market value forecast 13
Five Forces Analysis 14
Summary 14
Buyer power 15
Supplier power 17
New entrants 19
Threat of substitutes 21
Degree of rivalry 22
Leading Companies 24
Ethniki Insurance 24
Eurolife ERB Insurance Group Holdings S.A. 25
Interamerican Group 26
Nationale-Nederlanden Levensverzekering Maatschappij N.V. 27
Macroeconomic Indicators 28
Country data 28
Methodology 30
Industry associations 31
Related MarketLine research 31
Appendix 32
About MarketLine 32

List Of Tables


Table 1: Greece insurance market value: $ billion, 2013-17
Table 2: Greece insurance market category segmentation: $ billion, 2017
Table 3: Greece insurance market geography segmentation: $ billion, 2017
Table 4: Greece insurance market share: % share, by value, 2017
Table 5: Greece insurance market value forecast: $ billion, 2017-22
Table 6: Ethniki Insurance: key facts
Table 7: Eurolife ERB Insurance Group Holdings S.A.: key facts
Table 8: Interamerican Group: key facts
Table 9: Nationale-Nederlanden Levensverzekering Maatschappij N.V.: key facts
Table 10: Greece size of population (million), 2013-17
Table 11: Greece gdp (constant 2005 prices, $ billion), 2013-17
Table 12: Greece gdp (current prices, $ billion), 2013-17
Table 13: Greece inflation, 2013-17
Table 14: Greece consumer price index (absolute), 2013-17
Table 15: Greece exchange rate, 2013-17

List Of Figures


Figure 1: Greece insurance market value: $ billion, 2013-17
Figure 2: Greece insurance market category segmentation: % share, by value, 2017
Figure 3: Greece insurance market geography segmentation: % share, by value, 2017
Figure 4: Greece insurance market share: % share, by value, 2017
Figure 5: Greece insurance market value forecast: $ billion, 2017-22
Figure 6: Forces driving competition in the insurance market in Greece, 2017
Figure 7: Drivers of buyer power in the insurance market in Greece, 2017
Figure 8: Drivers of supplier power in the insurance market in Greece, 2017
Figure 9: Factors influencing the likelihood of new entrants in the insurance market in Greece, 2017
Figure 10: Factors influencing the threat of substitutes in the insurance market in Greece, 2017
Figure 11: Drivers of degree of rivalry in the insurance market in Greece, 2017

Smoothened Homolog - Pipeline Review, H1 2020

Smoothened Homolog - Pipeline Review, H1 2020Smoothened Homolog (Protein Gx or SMO) pipeline Target constitutes close to 14 molecules. Out of which approximately 11 molecules are developed by companies and

USD 3500 View Report

Metabotropic Glutamate Receptor 4 - Pipeline Review, H1 2020

Metabotropic Glutamate Receptor 4 - Pipeline Review, H1 2020According to the recently published report Metabotropic Glutamate Receptor 4 Pipeline Review, H1 2020; Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4

USD 3500 View Report

Smoothened Homolog - Pipeline Review, H1 2020

Smoothened Homolog - Pipeline Review, H1 2020Smoothened Homolog (Protein Gx or SMO) pipeline Target constitutes close to 14 molecules. Out of which approximately 11 molecules are developed by companies and

USD 3500 View Report

Metabotropic Glutamate Receptor 4 - Pipeline Review, H1 2020

Metabotropic Glutamate Receptor 4 - Pipeline Review, H1 2020According to the recently published report Metabotropic Glutamate Receptor 4 Pipeline Review, H1 2020; Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4

USD 3500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available